SCHEMBL19082367

SCHEMBL19082367

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5cc6sc7c8ccccc8ccc7c6c6sc7ccccc7c56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.37
CYP1B1 Q16678 5/20 0.37
CYP1A2 P05177 4/20 0.37
NQO1 P15559 1/20 0.35
NQO2 P16083 1/20 0.35
ALOX5 P09917 1/20 0.34
PTPN1 P18031 1/20 0.34
ANPEP P15144 1/20 0.33
SOS1 Q07889 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33
HIF1A Q16665 2/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082114 0.95 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL17945092 0.95 ALOX5 (0.35) NQO1NQO2ALOX5PTPN1ANPEP
SCHEMBL19082327 0.90 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL17945463 0.89 ALOX5 (0.37) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082239 0.89 CA12 (0.38) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082368 0.89 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19080333 0.88 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082383 0.87 ALOX5 (0.38) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL17944235 0.84 ALOX5 (0.38) NQO1NQO2ALOX5PTPN1ANPEP
SCHEMBL17945093 0.84 ALOX5 (0.35) NQO1NQO2ALOX5PTPN1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.